Teva Recalls Lidocaine Patches Due to Missing Lot and Expiration Dates
Teva Pharmaceuticals is recalling Lidocaine 5% Patches because individual pouches are missing lot and expiration dates. The recall covers 28,596 cartons distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (missing lot/expiration dates) without reported injuries or illnesses, fitting the 'Moderate' criteria for minor labeling errors or low-risk issues.
Plain-English summary
Teva Pharmaceuticals USA is recalling Lidocaine 5% Patches, packaged in 30-count cartons, due to a labeling defect. The individual transdermal pouches within the cartons are missing or have incorrect lot and expiration dates, although the carton itself contains the correct information. The affected product is identified by Carton Lot # 1383513B, Patch Lot # 1383513, and an expiration date of 03/2022.
The recall involves 28,596 cartons of the prescription-only medication, which was distributed nationwide in the United States. The product was manufactured by Actavis Laboratories UT, Inc., and distributed by Actavis Pharma, Inc.
Consumers and healthcare providers should stop using the affected Lidocaine 5% Patches and contact their pharmacist or healthcare provider for a replacement or refund. This recall is classified as Class II by the FDA, indicating a situation where use of the product could cause temporary or medically reversible health consequences.
The recalled product
- Product
- LIDOCAINE (LIDOCAINE)
- Brand
- LIDOCAINE
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Topical Anesthetic
- Hazard
- Affected units
- 28,596
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Carton Lot # 1383513B
- Patch Lot # 1383513
- Exp date 03/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateLidocaine and epinephrine dental cartridges recalled over cracked containers
FDA (Drugs) · 2025-12-24
- ModerateLidocaine Patch 5% Recalled for Typographical Error on Label
FDA (Drugs) · 2023-05-10
- ModerateFDA Recalls Prescription Lidocaine Patch Due to Temperature Exposure
FDA (Drugs) · 2022-06-15
- ModeratePrescription Lidocaine Patches Recalled for Temperature-Related Quality Deviations
FDA (Drugs) · 2022-06-15
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02